4.2 Article

The research progress of circular RNAs in hematological malignancies

Journal

HEMATOLOGY
Volume 24, Issue 1, Pages 727-731

Publisher

TAYLOR & FRANCIS LTD
DOI: 10.1080/16078454.2019.1669924

Keywords

Circular RNA; hematological malignancy; AML; CML; CLL; function; biomarker; therapeutic target

Categories

Funding

  1. Jiangsu Province health committee [H2018085]
  2. Science and Technology Foundation of Huai'an City [HAB201810]
  3. '333 Projects' Foundation of Jiangsu Province [BRA2017243]
  4. '533 Projects' Foundation of Huai'an City [HAA201739]
  5. Science and Technology Development Fund of Huai'an City [HAS201608]
  6. Innovation Team Foundation of The Affiliated Huaian People's Hospital of Nanjing Medical University [1]

Ask authors/readers for more resources

Objectives: Circular RNA (circRNA), a covalently closed loop structure lacking poly-adenylated tails, has attracted attention with the rapid development of its detection techniques such as bioinformatics and RNA sequencing. CircRNA plays important roles in several cell signaling pathways that are associated with cancer biogenesis, including acting as miRNA sponges, transcriptional regulators, protein adaptors and protein translators. The role of circRNA in hematological malignancy has been revealed recently. The purpose of this study was to explore the role of circRNA in hematological malignancy. Methods: A comprehensive literature review was conducted through Pubmed to summarize the published evidence on the circRNAs in hematological malignancies. English literature sources since 1976 were searched, using the terms circRNA, hematological malignancy. Results: CircRNAs can regulate the gene expression of hematological malignancies mainly through adsorbing several miRNAs. Some circRNAs are potential biomarkers and therapeutic targets in hematological malignancies, such as acute myloid leukemia (AML), chronic myeloid leukemia (CML) and chronic lymphocytic leukemia (CLL). Conclusion: CircRNAs play an important biological function and have great diagnostic and prognostic value in hematological malignancies.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.2
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available